Drug Policy Archives - Page 16 of 58

Survey shows stereotype of the lazy, lefty marijuana smoker doesn’t reflect reality

Commentary by Geoffrey Lawrence and Madison Carlino

Nonprofit announces new partnership with Ohio to tackle opioid addiction with ibogaine

Commentary by Gregory Ferenstein and Leonard Gilroy

A policy framework for personal psychedelics licenses

Policy Brief by Gregory Ferenstein

The Breakthrough Therapies Act could spur research and improve access to life-saving drugs

Commentary by Geoffrey Lawrence and Madison Carlino

Psychedelics Policy Newsletter: Impactful ibogaine study, bill introduced in New Hampshire, and more

Psychedelics Policy Newsletter by Gregory Ferenstein

Marijuana social equity programs should be redesigned to focus on restorative justice

Commentary by Geoffrey Lawrence and Khurshid Khoja

State psychedelics policy roundup: January 2024 edition

Commentary by Gregory Ferenstein

New Hampshire proposes a unique approach to medical psychedelics

Commentary by Gregory Ferenstein

The implications of federal cannabis rescheduling

Policy Brief by Michelle Minton

More Drug Policy